BCRX • NASDAQ
BioCryst Pharmaceuticals, Inc.
$10.84
After Hours:
$10.75
(0.83%)-0.090
Closed: Jul 1, 4:34:32 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed securityUS headquartered
Previous close
$10.58
Day range
$10.33 - $10.92
Year range
$7.61 - $19.99
Market cap
2.01B USD
Avg Volume
3.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Financial performance
Revenue
Net income
(USD)Mar 2022Y/Y change
Revenue
49.92M161.94%
Operating expense
34.28M55.02%
Net income
-74.20M-15.42%
Earnings per share
-0.40-11.11%
EBITDA
-49.64M3.04%
Effective tax rate
-0.38%
Financial performance
Total assets
Total liabilities
(USD)Mar 2022Y/Y change
Cash and short-term investments
443.47M84.50%
Total assets
527.72M85.54%
Total liabilities
691.94M92.51%
Total equity
-164.22M
Shares outstanding
185.58M
Price to book
-12.02
Return on assets
-22.38%
Return on capital
-26.71%
Financial performance
Net change in cash
(USD)Mar 2022Y/Y change
Net income
-74.20M-15.42%
Cash from operations
-77.80M-27.52%
Cash from investing
-38.47M-362.20%
Cash from financing
7.36M153.66%
Net change in cash
-108.88M-150.65%
Free cash flow
-69.28M-41.76%
About
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Founded
1986
Employees
358
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for